Background: Currently, quantitative measurement of global cerebral blood fl
ow (CBF) at bedside is not widely performed. The aim of the present study w
as to evaluate a newly developed method for bedside measurement of CBF base
d on thermodilution in a clinical setting.
Methods: The investigation was performed in 14 anesthetized patients before
coronary bypass surgery. CBF was altered by hypocapnia, normocapnia, and h
ypercapnia. CBF was measured simultaneously by the Kety-Schmidt inert-gas t
echnique with argon and a newly developed transcerebral double-indicator di
lution technique (TCID). For TCID, bolus injections of ice-cold indocyanine
green were performed via a central venous line, and the resulting thermo-d
ye dilution curves were recorded simultaneously in the aorta and the jugula
r bulb using combined fiberoptic thermistor catheters. CBF was calculated f
rom the mean transit times of the indicators through the brain.
Results: Both methods of measurement of CBF indicate a decrease during hypo
capnia and an increase during hypercapnia, whereas cerebral metabolic rate
remained unchanged. Bias between CBFTCID and CBFargon was --7.1 +/- 2.2 (SE
M) mi min-l 100 g(-1); precision (+/- 2.SD of differences) between methods
was 26.6 ml.min(-1).100 g(-1).
Conclusions: In the clinical setting, TCID was feasible and less time-consu
ming than alternative methods. The authors con-elude that TCID is an altern
ative method to measure global CBF at bedside and offers a new opportunity
to monitor cerebral perfusion of patients.